XML 135 R89.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based payments - Disclosure of reconciliation of AGAs (Details) - shares
6 Months Ended 12 Months Ended 18 Months Ended
Sep. 05, 2024
Jul. 11, 2024
May 23, 2024
Mar. 28, 2024
Jan. 02, 2024
Dec. 01, 2023
Sep. 28, 2023
Jul. 11, 2023
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2024
Free Shares (AGA)                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   2,601,296  
Number of instruments issued (in shares)                 2,601,296 1,946,125 4,547,421
Number of instruments lapsed (in shares)                   (744,362)  
Number of instruments exercised (in shares)                   (415,019)  
Number of instruments outstanding, ending balance (in shares)                 2,601,296 3,388,040 3,388,040
AGA-2023-1                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   1,382,796  
Number of instruments issued (in shares)               1,382,796      
Number of instruments lapsed (in shares)                   (212,737)  
Number of instruments exercised (in shares)                   (390,019)  
Number of instruments outstanding, ending balance (in shares)                 1,382,796 780,040 780,040
AGA-2023-2                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   100,000  
Number of instruments issued (in shares)               100,000      
Number of instruments exercised (in shares)                   (25,000)  
Number of instruments outstanding, ending balance (in shares)                 100,000 75,000 75,000
AGA-2023-3                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   731,500  
Number of instruments issued (in shares)             731,500        
Number of instruments lapsed (in shares)                   (245,625)  
Number of instruments outstanding, ending balance (in shares)                 731,500 485,875 485,875
AGA-2023-4                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   254,250  
Number of instruments issued (in shares)             254,250        
Number of instruments lapsed (in shares)                   (41,000)  
Number of instruments outstanding, ending balance (in shares)                 254,250 213,250 213,250
AGA-2023-5                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                   132,750  
Number of instruments issued (in shares)           132,750          
Number of instruments lapsed (in shares)                   (51,500)  
Number of instruments outstanding, ending balance (in shares)                 132,750 81,250 81,250
AGA-2024-1                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)         1,549,125         1,549,125  
Number of instruments lapsed (in shares)                   (193,500)  
Number of instruments outstanding, ending balance (in shares)                   1,355,625 1,355,625
AGA-2024-2                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)       22,500           22,500  
Number of instruments outstanding, ending balance (in shares)                   22,500 22,500
AGA-2024-3                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)     38,500             38,500  
Number of instruments outstanding, ending balance (in shares)                   38,500 38,500
AGA-2024-4                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)   93,000               93,000  
Number of instruments outstanding, ending balance (in shares)                   93,000 93,000
AGA-2024-5                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)   25,000               25,000  
Number of instruments outstanding, ending balance (in shares)                   25,000 25,000
AGA-2024-6                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares)   20,000               20,000  
Number of instruments outstanding, ending balance (in shares)                   20,000 20,000
AGA-2024-7                      
Disclosure of terms and conditions of share-based payment arrangement [line items]                      
Number of instruments outstanding, beginning balance (in shares)                      
Number of instruments issued (in shares) 198,000                 198,000  
Number of instruments outstanding, ending balance (in shares)                   198,000 198,000